Unable to display view head.php file not found.
 
 

James A. Reiffel, MD - Novel Oral Anticoagulants - Figure 40

Bleeding Events for Rivaroxaban and Warfarin

Regarding safety, across the major categories of bleeding – major and non-major clinically relevant bleeding – there were no differences between rivaroxaban and warfarin.

 Reiffel JA. Am J Med 2013; 126: 00-00.

Complete references for all slides

References

[112] Xarelto® (rivaroxaban) film-coated oral tablets [prescribing information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; 2011. Revised: November 2012.

Unable to display view foot.php file not found.